DOACs - advances and limitations in real world

• Main Author: Lee, L.H
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Review
• Published: 2020
• Subjects: antivitamin K; apixaban; dabigatran; edoxaban; enoxaparin; idarucizumab; prothrombin; recombinant blood clotting factor 7a; rivaroxaban; warfarin; anticoagulant therapy; Asian; atrial fibrillation; bleeding; brain hemorrhage; cerebrovascular accident; cost effectiveness analysis; drug choice; drug efficacy; drug safety; gastrointestinal hemorrhage; heart infarction; hemodialysis; human; off label drug use; orthopedic surgery; partial thromboplastin time; patient care; prophylaxis; prothrombin time; Review; thrombin time; thromboprophylaxis; venous thromboembolism
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/181339
• Institution: National University of Singapore

10.1186/s12959-016-0111-3